New Risk • May 01
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 39% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Earnings have declined by 15% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.5% net profit margin). New Risk • Apr 29
New major risk - Revenue and earnings growth Earnings have declined by 8.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 8.3% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (133% cash payout ratio). Profit margins are more than 30% lower than last year (0.9% net profit margin). Ankündigung • Apr 29
Longxing Technology Group Co., Ltd., Annual General Meeting, May 21, 2026 Longxing Technology Group Co., Ltd., Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shahe, Hebei China Ankündigung • Mar 31
Longxing Technology Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Longxing Technology Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥5.73, the stock trades at a trailing P/E ratio of 31.7x. Average trailing P/E is 47x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years. Ankündigung • Dec 31
Longxing Technology Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026 Longxing Technology Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026 Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: CN¥0.026 (vs CN¥0.10 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.026 (down from CN¥0.10 in 3Q 2024). Revenue: CN¥1.12b (up 2.9% from 3Q 2024). Net income: CN¥12.7m (down 75% from 3Q 2024). Profit margin: 1.1% (down from 4.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 3% per year and the company’s share price has also increased by 3% per year. Ankündigung • Sep 30
Longxing Technology Group Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Longxing Technology Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Ankündigung • Jul 02
Longxing Technology Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Longxing Technology Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Declared Dividend • Jun 06
Dividend of CN¥0.12 announced Dividend of CN¥0.12 is the same as last year. Ex-date: 10th June 2025 Payment date: 10th June 2025 Dividend yield will be 1.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (41% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.1% per year over the past 6 years. However, payments have been volatile during that time. Earnings per share has grown by 49% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥5.47, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 1.8% over the past three years. Ankündigung • Apr 04
Longxing Technology Group Co., Ltd. Proposes Final Cash Distribution for 2024 Longxing Technology Group Co., Ltd. announced on 02 April 2025 the profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY1.20000000. Reported Earnings • Apr 02
Full year 2024 earnings released: EPS: CN¥0.29 (vs CN¥0.23 in FY 2023) Full year 2024 results: EPS: CN¥0.29 (up from CN¥0.23 in FY 2023). Revenue: CN¥4.36b (up 1.9% from FY 2023). Net income: CN¥142.1m (up 29% from FY 2023). Profit margin: 3.3% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year. Ankündigung • Apr 02
Longxing Technology Group Co., Ltd., Annual General Meeting, Apr 23, 2025 Longxing Technology Group Co., Ltd., Annual General Meeting, Apr 23, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shahe, Hebei China Ankündigung • Mar 31
Longxing Technology Group Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Longxing Technology Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Ankündigung • Dec 31
Longxing Chemical Stock Co., Ltd. to Report Fiscal Year 2024 Results on Apr 02, 2025 Longxing Chemical Stock Co., Ltd. announced that they will report fiscal year 2024 results on Apr 02, 2025 Ankündigung • Nov 21
Longxing Chemical Stock Co., Ltd. (SZSE:002442) signed an equity acquisition framework agreement to acquire CSRC China (Chongqing) Corporation from Csrc (Singapore) Pte Ltd. Longxing Chemical Stock Co., Ltd. (SZSE:002442) signed an equity acquisition framework agreement to acquire CSRC China (Chongqing) Corporation from Csrc (Singapore) Pte Ltd on November 20, 2024. Upon completion of the conditions stipulated in the equity acquisition framework agreement, CSRC (Singapore) Pte Ltd and Longxing Chemical Stock Co., Ltd. will negotiate and sign a formal share purchase agreement.
If this transaction has not obtained approvals, record filings, authorizations, or permissions from the competent authorities of mainland China within a specified period (if applicable), the equity acquisition framework agreement will be automatically terminated. Reported Earnings • Oct 28
Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.098 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.10 (up from CN¥0.098 in 3Q 2023). Revenue: CN¥1.09b (up 4.5% from 3Q 2023). Net income: CN¥49.6m (up 5.1% from 3Q 2023). Profit margin: 4.6% (up from 4.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥4.79, the stock trades at a trailing P/E ratio of 20.7x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 30% over the past three years. Ankündigung • Sep 30
Longxing Chemical Stock Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Longxing Chemical Stock Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 New Risk • Sep 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (2.5% increase in shares outstanding). Reported Earnings • Aug 16
Second quarter 2024 earnings released: EPS: CN¥0.073 (vs CN¥0.091 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.073 (down from CN¥0.091 in 2Q 2023). Revenue: CN¥1.03b (flat on 2Q 2023). Net income: CN¥35.3m (down 20% from 2Q 2023). Profit margin: 3.4% (down from 4.2% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year whereas the company’s share price has fallen by 18% per year. Ankündigung • Jun 29
Longxing Chemical Stock Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Longxing Chemical Stock Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024 Ankündigung • May 02
Longxing Chemical Stock Co., Ltd. Proposes Final Dividend for 2023 Longxing Chemical Stock Co., Ltd. announced on 30 April 2024 the profit distribution proposal for 2023 as follows: Cash dividend/10 shares (tax included): CNY 1.20000000. Ankündigung • May 01
Longxing Chemical Stock Co., Ltd., Annual General Meeting, May 21, 2024 Longxing Chemical Stock Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shahe, Hebei China Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.026 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.056 (up from CN¥0.026 in 1Q 2023). Revenue: CN¥1.00b (down 11% from 1Q 2023). Net income: CN¥27.2m (up 114% from 1Q 2023). Profit margin: 2.7% (up from 1.1% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥4.14, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Ankündigung • Mar 30
Longxing Chemical Stock Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Longxing Chemical Stock Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥4.38, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 13% over the past three years. Board Change • Jan 18
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Non-Independent Director Yuping Peng was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥5.74, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 53% over the past three years. Ankündigung • Dec 30
Longxing Chemical Stock Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024 Longxing Chemical Stock Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Dec 26
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥6.68, the stock trades at a trailing P/E ratio of 28.8x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 56% over the past three years. Ankündigung • Dec 22
Longxing Chemical Stock Co., Ltd. Announces Board Appointments Longxing Chemical Stock Co., Ltd. at its Extraordinary General Meeting of 2023 held on 20 December 2023, approved election of Yang Jin, Qiao Xixue, Ma Weifeng and Peng Yuping as non-independent directors and election of Liu Pengfei as independent director. Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.073 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.098 (up from CN¥0.073 in 3Q 2022). Revenue: CN¥1.04b (down 13% from 3Q 2022). Net income: CN¥47.2m (up 36% from 3Q 2022). Profit margin: 4.5% (up from 2.9% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. New Risk • Aug 23
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). High level of non-cash earnings (22% accrual ratio). Reported Earnings • Aug 19
Second quarter 2023 earnings released: EPS: CN¥0.091 (vs CN¥0.096 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.091 (down from CN¥0.096 in 2Q 2022). Revenue: CN¥1.04b (down 13% from 2Q 2022). Net income: CN¥43.9m (down 7.8% from 2Q 2022). Profit margin: 4.2% (up from 4.0% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 18
Full year 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.36 in FY 2021) Full year 2022 results: EPS: CN¥0.21 (down from CN¥0.36 in FY 2021). Revenue: CN¥4.56b (up 33% from FY 2021). Net income: CN¥103.7m (down 40% from FY 2021). Profit margin: 2.3% (down from 5.0% in FY 2021). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. 2 highly experienced directors. 2 independent directors (5 non-independent directors). Chairman of the Supervisory Board Hegang Hou is the most experienced director on the board, commencing their role in 2008. Independent Director Liming Yan was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 31
Third quarter 2022 earnings released: EPS: CN¥0.073 (vs CN¥0.04 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.073 (up from CN¥0.04 in 3Q 2021). Revenue: CN¥1.20b (up 48% from 3Q 2021). Net income: CN¥34.8m (up 83% from 3Q 2021). Profit margin: 2.9% (up from 2.4% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 26% share price gain to CN¥6.86, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 26% over the past three years. Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.096 (vs CN¥0.09 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.096 (up from CN¥0.09 in 2Q 2021). Revenue: CN¥1.20b (up 40% from 2Q 2021). Net income: CN¥47.7m (up 10% from 2Q 2021). Profit margin: 4.0% (down from 5.0% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Aug 31
Now 20% undervalued Over the last 90 days, the stock is up 3.2%. The fair value is estimated to be CN¥6.85, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years. Earnings per share has grown by 45%. Buying Opportunity • Jun 29
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 10%. The fair value is estimated to be CN¥7.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years. Earnings per share has grown by 45%. Ankündigung • Jun 17
Longxing Chemical Stock Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 22, 2022 Longxing Chemical Stock Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.00000000 on A shares for the year 2021. Record date is June 21, 2022. Ex-date is June 22, 2022. Payment date is June 22, 2022. Ankündigung • May 12
Longxing Chemical Stock Co., Ltd. Approves Cash Dividend for the Year 2021 Longxing Chemical Stock Co., Ltd. announced held its Annual General Meeting of 2021 on 06 May 2022, approved Cash dividend/10 shares (tax included): CNY 1.00000000 for the year 2021. Ankündigung • Apr 27
Longxing Chemical Stock Co., Ltd. announced that it expects to receive CNY 1.6036566 billion in funding Longxing Chemical Stock Co., Ltd. announced that it has entered into a share subscription agreement for a private placement of not more than 147,246,000 A shares for gross proceeds of not more than CNY 1,603,656,600 on April 25, 2022. The transaction included participation from not more than 35, including Liu Pengda, who will subscribe to 5,000,000-10,000,000 shares. The shares Liu Pengda subscribes to cannot be transferred within 18 months from the closing of the transaction. The shares the other investors subscribe to cannot be transferred within 6 months from the closing of the transaction. The transaction has been approved in the 3rd extraordinary meeting of 2022 of the company’s 5th directorate, and is subject to the approvals of the company’s shareholders and the China Securities Regulatory Commission. The issue price shall not be less than 80% of the average price in the 20 trading days before the pricing reference date. Board Change • Apr 27
High number of new directors There are 7 new directors who have joined the board in the last 3 years. Independent Director Liming Yan was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 16
Full year 2021 earnings released: EPS: CN¥0.36 (vs CN¥0.16 in FY 2020) Full year 2021 results: EPS: CN¥0.36 (up from CN¥0.16 in FY 2020). Revenue: CN¥3.44b (up 50% from FY 2020). Net income: CN¥171.6m (up 122% from FY 2020). Profit margin: 5.0% (up from 3.4% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 01
Third quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.039 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥809.1m (up 32% from 3Q 2020). Net income: CN¥19.0m (up 2.5% from 3Q 2020). Profit margin: 2.4% (down from 3.0% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 22% share price decline to CN¥7.43, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 34x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.003 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥858.0m (up 73% from 2Q 2020). Net income: CN¥43.2m (up CN¥41.9m from 2Q 2020). Profit margin: 5.0% (up from 0.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥8.79, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 26% share price gain to CN¥7.84, the stock trades at a trailing P/E ratio of 24.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years. Valuation Update With 7 Day Price Move • May 12
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥6.38, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS CN¥0.16 (vs CN¥0.04 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥2.30b (down 18% from FY 2019). Net income: CN¥77.5m (up 303% from FY 2019). Profit margin: 3.4% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year whereas the company’s share price has fallen by 24% per year. Ankündigung • Mar 09
Longxing Chemical Stock Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021 Longxing Chemical Stock Co., Ltd. announced that they will report fiscal year 2020 results on Apr 20, 2021 Is New 90 Day High Low • Feb 24
New 90-day high: CN¥5.13 The company is up 3.0% from its price of CN¥5.00 on 26 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥3.97 The company is down 8.0% from its price of CN¥4.32 on 13 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Ankündigung • Dec 02
Longxing Chemical Stock Co., Ltd. Announces Executive Appointments Longxing Chemical Stock Co., Ltd. announced at the EGM held on November 30, 2020, the shareholders approved Liu Pengda, Li Ying, Ma Baoliang and Bian Tongle as non-independent directors and the board approved Cheng Hua, Zhou Jie and Wang Yong as independent directors, and the board approved Hou Hegang and Huo Lijun as supervisors. Is New 90 Day High Low • Nov 23
New 90-day high: CN¥5.23 The company is up 7.0% from its price of CN¥4.88 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥3.98 The company is down 13% from its price of CN¥4.60 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥16.3m, down 72% from the prior year. Total revenue was CN¥2.25b over the last 12 months, down 23% from the prior year. Ankündigung • Oct 20
Longxing Chemical Stock Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020 Longxing Chemical Stock Co., Ltd. announced that they will report Q3, 2020 results on Oct 28, 2020 Ankündigung • Jul 25
Longxing Chemical Stock Co., Ltd. to Report First Half, 2020 Results on Aug 21, 2020 Longxing Chemical Stock Co., Ltd. announced that they will report first half, 2020 results on Aug 21, 2020 
